Related references
Note: Only part of the references are listed.RYR2 Channel Inhibition Is the Principal Mechanism of Flecainide Action in CPVT
Dmytro O. Kryshtal et al.
CIRCULATION RESEARCH (2021)
Use of Flecainide for the Treatment of Atrial Fibrillation
Debra S. Echt et al.
AMERICAN JOURNAL OF CARDIOLOGY (2020)
Peptide mimetic compounds can activate or inhibit cardiac and skeletal ryanodine receptors
Ken Robinson et al.
LIFE SCIENCES (2020)
Ion channel gating in cardiac ryanodine receptors from the arrhythmic RyR2-P2328S mouse
Samantha C. Salvage et al.
JOURNAL OF CELL SCIENCE (2019)
Safety and efficacy of flecainide for patients with catecholaminergic polymorphic ventricular tachycardia A systematic review and meta-analysis
Guangqiang Wang et al.
MEDICINE (2019)
Ryanodine Receptor Open Times Are Determined in the Closed State
Michael Fill et al.
BIOPHYSICAL JOURNAL (2018)
Multiple targets for flecainide action: implications for cardiac arrhythmogenesis
Samantha C. Salvage et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Ryanodine receptor modification and regulation by intracellular Ca2+ and Mg2+ in healthy and failing human hearts
K. Walweel et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2017)
A cryo-EM-based model of phosphorylation- and FKBP12.6-mediated allosterism of the cardiac ryanodine receptor
Sonali Dhindwal et al.
SCIENCE SIGNALING (2017)
A cryo-EM-based model of phosphorylation- and FKBP12.6-mediated allosterism of the cardiac ryanodine receptor
Sonali Dhindwal et al.
SCIENCE SIGNALING (2017)
The RyR2-P2328S mutation downregulates Nav1.5 producing arrhythmic substrate in murine ventricles
Feifei Ning et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2016)
Structural Basis for Gating and Activation of RyR1
Amedee des Georges et al.
CELL (2016)
Flecainide monotherapy is an option for selected patients with catecholaminergic polymorphic ventricular tachycardia intolerant of β-blockade
Gareth J. Padfield et al.
HEART RHYTHM (2016)
Flecainide exerts paradoxical effects on sodium currents and atrial arrhythmia in murine RyR2-P2328S hearts
S. C. Salvage et al.
ACTA PHYSIOLOGICA (2015)
The Mechanism of Flecainide Action in CPVT Does Not Involve a Direct Effect on RyR2
Mark L. Bannister et al.
CIRCULATION RESEARCH (2015)
Catecholaminergic Polymorphic Ventricular Tachycardia in Children Analysis of Therapeutic Strategies and Outcomes From an International Multicenter Registry
Thomas M. Roston et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2015)
Multiple Modes of Ryanodine Receptor 2 Inhibition by Flecainide
D. Mehra et al.
MOLECULAR PHARMACOLOGY (2014)
Atrial arrhythmia, triggering events and conduction abnormalities in isolated murine RyR2-P2328S hearts
J. H. King et al.
ACTA PHYSIOLOGICA (2013)
ATP interacts with the CPVT mutation-associated central domain of the cardiac ryanodine receptor
Lynda Blayney et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
Flecainide reduces Ca2+ spark and wave frequency via inhibition of the sarcolemmal sodium current
Markus B. Sikkel et al.
CARDIOVASCULAR RESEARCH (2013)
Conduction Slowing Contributes to Spontaneous Ventricular Arrhythmias in Intrinsically Active Murine RyR2-P2328S Hearts
Yanmin Zhang et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2013)
A Novel Ryanodine Receptor Mutation Linked to Sudden Death Increases Sensitivity to Cytosolic Calcium
Albano C. Meli et al.
CIRCULATION RESEARCH (2011)
Multiple Actions of the Anthracycline Daunorubicin on Cardiac Ryanodine Receptors
Amy D. Hanna et al.
MOLECULAR PHARMACOLOGY (2011)
Frequency and release flux of calcium sparks in rat cardiac myocytes: a relation to RYR gating
Alexandra Zahradnikova et al.
JOURNAL OF GENERAL PHYSIOLOGY (2010)
Flecainide inhibits arrhythmogenic Ca2+ waves by open state block of ryanodine receptor Ca2+ release channels and reduction of Ca2+ spark mass
Fredrick A. Hilliard et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2010)
Intracellular calcium modulation of voltage-gated sodium channels in ventricular myocytes
Simona Casini et al.
CARDIOVASCULAR RESEARCH (2009)
Unique isoform-specific properties of calsequestrin in the heart and skeletal muscle
Lan Wei et al.
CELL CALCIUM (2009)
Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans
Hiroshi Watanabe et al.
NATURE MEDICINE (2009)
Physiological consequences of the P2328S mutation in the ryanodine receptor (RyR2) gene in genetically modified murine hearts
C. A. Goddard et al.
ACTA PHYSIOLOGICA (2008)
Association of atrial arrhythmia and sinus node dysfunction in patients with catecholaminergic polymorphic ventricular tachycardia
Naokata Sumitomo et al.
CIRCULATION JOURNAL (2007)
Bidirectional ventricular tachycardia and fibrillation elicited in a knock-in mouse model carrier of a mutation in the cardiac ryanodine receptor
M Cerrone et al.
CIRCULATION RESEARCH (2005)
Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak
SE Lehnart et al.
CIRCULATION (2004)
A calcium sensor in the sodium channel modulates cardiac excitability
HL Tan et al.
NATURE (2002)
Characteristics of irreversible ATP activation suggest that native skeletal ryanodine receptors can be phosphorylated via an endogenous CaMKII
AF Dulhunty et al.
BIOPHYSICAL JOURNAL (2001)
Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia
PJ Laitinen et al.
CIRCULATION (2001)
Transmembrane redox sensor of ryanodine receptor complex
W Feng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
